<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83803">
  <stage>Registered</stage>
  <submitdate>25/01/2012</submitdate>
  <approvaldate>25/01/2012</approvaldate>
  <actrnumber>ACTRN12612000123842</actrnumber>
  <trial_identification>
    <studytitle>Changes in bone structure, lean mass, and glucose metabolism after stroke: a prospective study</studytitle>
    <scientifictitle>Changes in bone structure, lean mass, and glucose metabolism in people with stroke: a two year observation study</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Acute Stroke</healthcondition>
    <healthcondition>bone structure and density</healthcondition>
    <healthcondition>glucose metabolism</healthcondition>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Ischaemic</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2>Haemorrhagic</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This is a two year longitudinal, observation study of changes to bone density and structure, body composition and glucose metabolism after stroke</interventions>
    <comparator>Observational study - not controlled (however, primary outcome results will be compared to 'normal' population age matched controls where possible)</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Bone structure and volumetric bone mineral density of paretic and non-paretic side radius and tibia, measured by high resolution peripheral quantitative computed tomography (pQCT)</outcome>
      <timepoint>Baseline (within 2 weeks of stroke), 6-, 12-,18- and 24 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Body composition: total body and regional bone mineral density and fat/ muscle mass measured by dual-energy xray absorptiometry (DXA)</outcome>
      <timepoint>Baseline, 1-, 3-, 6-, 12-, 18- and 24- months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Glucose tolerance measured by two hour oral glucose tolerance test</outcome>
      <timepoint>Baseline, 6-, 12-,18- and 24 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Physical activity monitoring (PAL2 accelerometer)</outcome>
      <timepoint>Baseline, 1-, 3-, 6-, 12-, 18- and 24- months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Blood markers of bone resorption and formation, including osteocalcin, C-telopeptide (CTX), pro-collagen type 1 n-terminal propeptide (PINP)</outcome>
      <timepoint>Baseline, 1-, 3-, 6-, 12-, 18- and 24- months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Physical assessment of muscle strength (hand held dynamometry), muscle tone (modified ashworth scale, motor control (Chedoke McMaster Stroke Assessment ), arm use (Motor Activity Log), walking ability (Functional Ambulation Category)</outcome>
      <timepoint>Baseline, 1-, 3-, 6-, 12-, 18- and 24- months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>The inclusion criteria are (1) a diagnosis of hemispheric stroke , (2) onset of stroke &lt;1 week, (3) medically stable, (4) unable to ambulate within the first week after stroke, (5) able to understand simple verbal commands.</inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>(1) brainstem or cerebellar stroke, (2) previous stroke in addition to the current admission, (3) known type 1 or type 2 diabetes (4) neurological conditions other than stroke (e.g. Parkinsons disease) (5) significant musculoskeletal condition impacting on function (e.g. amputation, severe arthritis), (6) current or recent use of bone resorption inhibitors</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/06/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>45</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>Florey Neuroscience Institutes</primarysponsorname>
    <primarysponsoraddress>Melbourne Brain Centre 
245 Burgundy St
Heidelberg
Victoria 3084</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Austin Health Medical Research Fund</fundingname>
      <fundingaddress>Office for Research,
Austin LifeSciences
Austin Health
PO Box 5555
Heidelberg
Victoria
Australia, 3084</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>LaTrobe University Faculty of Health Sciences</fundingname>
      <fundingaddress>LaTrobe University
Bundoora 3086
Victoria</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Australian Research Council</fundingname>
      <fundingaddress>GPO Box 2702
CANBERRA
ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Melbourne University Department of Medicine</sponsorname>
      <sponsoraddress>Endocrince Centre of Excellence
Level 2 Centaur Building
Austin Health
Repatriation Campus
Waterdale Road
West Heidelberg, Victoria 3081</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Hong Kong Polytechnic University</othercollaboratorname>
      <othercollaboratoraddress>Dept of Rehabilitation Sciences
Hong Kong Polytechnic University
Hung Hom
Kowloon</othercollaboratoraddress>
      <othercollaboratorcountry>Hong Kong</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is observing changes which occur to bone density and structure, muscle mass, and glucose metabolism (the way that the body converts sugars to energy), after stroke. We are investigating how these outcomes are influenced by physical activity after stroke. This information will be used in future designs of rehabilitation programs aimed at improving stroke patients' health and recovery.</summary>
    <trialwebsite>http://www.florey.edu.au/research/stroke/bone-structure-lean-mass-and-glucose-metabolism-early-after-stroke-a-prospective-study</trialwebsite>
    <publication>Borschmann, K. (2012). "Exercise protects bone after stroke, or does it? A narrative review of the evidence." Stroke Res Treat 2012: 103697.

Borschmann, K., S. IuIiano-Burns, et al. (2011). Low activity levels after stroke may contribute to poor skeletal and metabolic outcomes. Profile of patients admitted for stroke at Austin Health. Austin Health Research Week,. Melbourne.
	
Borschmann, K., M. Y. Pang, et al. (2011). "Stepping towards prevention of bone loss after stroke: a systematic review of the skeletal effects of physical activity after stroke." Int J Stroke.

Borschmann, K., M. Pang, et al. (2010). The skeletal effects of physical activity post stroke: a systematic review. Stroke Society of Australasia 21st Annual Scientific Meeting. Melbourne, Australia, International Journal of Stroke. 5.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Austin Health Human Ethics Committee</ethicname>
      <ethicaddress>Research Ethics Unit
PO Box 5555
Heidelberg 3084
Vic</ethicaddress>
      <ethicapprovaldate>1/04/2009</ethicapprovaldate>
      <hrec>H2009/03428</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>LaTrobe University Human Ethics Committee</ethicname>
      <ethicaddress>LaTrobe University
Bundoora 3086
Vic</ethicaddress>
      <ethicapprovaldate>21/12/2009</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof Julie Bernhardt</name>
      <address>Stroke Division
Florey Neuroscience Institutes
Melbourne Brain Centre
245 Burgundy St
Heidelberg 3084
Vic</address>
      <phone>+61 3 9035 7073</phone>
      <fax>+61 3 9496 2251</fax>
      <email>j.bernhardt@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Karen Borschmann</name>
      <address>Stroke Division
Florey Neuroscience Institutes
Melbourne Brain Centre
245 Burgundy St
Heidelberg 3084
Vic</address>
      <phone>+61 3 9035 7073</phone>
      <fax>+61 3 9496 2251</fax>
      <email>karenb@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Karen Borschmann</name>
      <address>Stroke Division
Florey Neuroscience Institutes
Melbourne Brain Centre
245 Burgundy St
Heidelberg 3084
Vic</address>
      <phone>+61 3 9035 7073</phone>
      <fax>+61 3 9496 2251</fax>
      <email>karenb@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>